K R Servelhere1, I Faber1, J A M Saute2, M Moscovich3, A D'Abreu1, L B Jardim2, H A G Teive3, I Lopes-Cendes4, M C Franca1. 1. Department of Neurology, University of Campinas - UNICAMP, Campinas, SP, Brazil. 2. Medical Genetics Service, Federal University of Rio Grande do Sul - UFRGS, Porto Alegre, RS, Brazil. 3. Neurology Service, Federal University of Paraná - UFPR, Curitiba, PR, Brazil. 4. Department of Medical Genetics, University of Campinas - UNICAMP, Campinas, SP, Brazil.
Abstract
BACKGROUND AND PURPOSE: Non-motor manifestations are frequently overlooked in degenerative disorders and little is known about their frequency and clinical relevance in SPG4 hereditary spastic paraplegia (SPG4-HSP). METHODS: Thirty patients with SPG4-HSP and 30 healthy controls answered the Modified Fatigue Impact Scale, Epworth Sleepiness Scale, Brief Pain Inventory and Beck Depression Inventory. Student's t test was used to compare groups and linear regression was used to assess correlations. RESULTS: Patients had higher fatigue scores than controls (31.0 ± 16.5 vs. 14.5 ± 16.0, P = 0.002) as well as pain (3.4 ± 2.7 vs. 1.0 ± 1.6, P = 0.001) and depression (12.7 ± 8.9 vs. 4.4 ± 3.8, P < 0.001, respectively). Fatigue was associated with depression and possibly with disease severity (P = 0.008 and 0.07, respectively). CONCLUSIONS: Fatigue, pain and depression are frequent and often severe manifestations in patients with SPG4-HSP.
BACKGROUND AND PURPOSE: Non-motor manifestations are frequently overlooked in degenerative disorders and little is known about their frequency and clinical relevance in SPG4 hereditary spastic paraplegia (SPG4-HSP). METHODS: Thirty patients with SPG4-HSP and 30 healthy controls answered the Modified Fatigue Impact Scale, Epworth Sleepiness Scale, Brief Pain Inventory and Beck Depression Inventory. Student's t test was used to compare groups and linear regression was used to assess correlations. RESULTS:Patients had higher fatigue scores than controls (31.0 ± 16.5 vs. 14.5 ± 16.0, P = 0.002) as well as pain (3.4 ± 2.7 vs. 1.0 ± 1.6, P = 0.001) and depression (12.7 ± 8.9 vs. 4.4 ± 3.8, P < 0.001, respectively). Fatigue was associated with depression and possibly with disease severity (P = 0.008 and 0.07, respectively). CONCLUSIONS:Fatigue, pain and depression are frequent and often severe manifestations in patients with SPG4-HSP.
Authors: Alberto R M Martinez; Marcelo B Nunes; Ingrid Faber; Anelyssa D'Abreu; Íscia Lopes-Cendes; Marcondes C França Journal: Cerebellum Date: 2017-02 Impact factor: 3.847
Authors: Krister W Fjermestad; Øivind J Kanavin; Eva E Næss; Lise B Hoxmark; Grete Hummelvoll Journal: Orphanet J Rare Dis Date: 2016-07-13 Impact factor: 4.123
Authors: Bas J H van Lith; Hans C J W Kerstens; Laura A C van den Bemd; Maria W G Nijhuis-van der Sanden; Vivian Weerdesteyn; Rob J E M Smeets; Klemens Fheodoroff; Bart P C van de Warrenburg; Alexander C H Geurts Journal: Orphanet J Rare Dis Date: 2020-03-04 Impact factor: 4.123